HEALTH TECHNOLOGY ASSESSMENT AND PERSONALIZED MEDICINE: ARE ECONOMIC EVALUATION GUIDELINES SUFFICIENT TO SUPPORT DECISION MAKING?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HEALTH TECHNOLOGY ASSESSMENT AND PERSONALIZED MEDICINE: ARE ECONOMIC EVALUATION GUIDELINES SUFFICIENT TO SUPPORT DECISION MAKING?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
Volume 30, Issue 02, Pages 179-187
Publisher
Cambridge University Press (CUP)
Online
2014-05-07
DOI
10.1017/s0266462314000142
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT
- (2013) Don Husereau et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer
- (2012) Malek B Hannouf et al. BMC CANCER
- Assessing Personalized Medicines in Australia
- (2012) Tracy Merlin et al. MEDICAL DECISION MAKING
- Guidelines for Health Technologies: Specific Guidance for Oncology Products in Canada
- (2012) Nicole Mittmann et al. VALUE IN HEALTH
- Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group
- (2012) Eric Faulkner et al. VALUE IN HEALTH
- Economic evaluation of targeted cancer interventions: Critical review and recommendations
- (2011) Elena B. Elkin et al. GENETICS IN MEDICINE
- Health technology assessment in the era of personalized health care
- (2011) Lidia Becla et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care
- (2011) Anirban Basu JOURNAL OF HEALTH ECONOMICS
- Cost-Utility Analyses of Diagnostic Laboratory Tests: A Systematic Review
- (2011) ChiHui Fang et al. VALUE IN HEALTH
- Health technology assessments in personalized medicine: illustrations for cost–effectiveness analysis
- (2011) Maarten J Postma et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Do Economic Evaluations of Targeted Therapy Provide Support for Decision Makers?
- (2011) Ilia L. Ferrusi et al. Journal of Oncology Practice
- Cost Effectiveness of Pharmacogenomics
- (2010) William B. Wong et al. PHARMACOECONOMICS
- Systematic review of pharmacoeconomic studies of pharmacogenomic tests
- (2010) Mathieu Beaulieu et al. PHARMACOGENOMICS
- The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
- (2009) Steven M Teutsch et al. GENETICS IN MEDICINE
- Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial
- (2009) N. Mittmann et al. JNCI-Journal of the National Cancer Institute
- Understanding the Medical and Nonmedical Value of Diagnostic Testing
- (2009) David W. Lee et al. VALUE IN HEALTH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started